About
Looking for more information?
Contact our responsive and friendly client services team any time.
INVESTOR PRESENTATION - BIOTRON LIMITED
BIOTRON LIMITED
Health Care
Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.
Read moreMarket Cap
56.86m
Price at Close
$0.081
4w avg. Volume
1.83m
4w avg. Turnover
$171.03k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| - | 29 Oct 2020 |
| - | 29 Oct 2020 |
| -1.04% | 14 Oct 2020 |
| -1.04% | 14 Oct 2020 |
| +2.22% | 08 Oct 2020 |
| -4.55% | 06 Sep 2020 |
| +15.79% | 03 Sep 2020 |
| +15.79% | 03 Sep 2020 |
| -5.05% | 27 Aug 2020 |
| -5.05% | 27 Aug 2020 |
Market Data
Current Price
$0.081
52WK HIGH
$0.185
52WK LOW
$0.05
1YR RETURN
+15.07%
1YR RETURN VS. SECTOR
-4.52%
90 DAY RETURN
-13.40%
ASX RANK
983
/2,011
SECTOR RANK
22
/47
SHARES OUTSTANDING
701.93m
BIOTRON LIMITED
Health Care
Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.
Read moreMarket Cap
56.86m
Price at Close
$0.081
4w avg. Volume
1.83m
4w avg. Turnover
$171.03k
ASX:BIT is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia